A large, multi‑billion‑dollar medical device manufacturer was producing high‑volume components for global markets under EU MDR, and FDA‑regulated conditions. The company relied heavily on third‑party ...

Introduction As medical device portfolios become more complex and regulatory scrutiny continues to intensify, many OEMs are re-evaluating how manufacturing, sterilization, and packaging fit into their...